| scholarly article | Q13442814 |
| P50 | author | Ian Bruce | Q30348366 |
| P2093 | author name string | Philip Pemberton | |
| Lee-Suan Teh | |||
| Jacqueline L Berry | |||
| Pauline Ho | |||
| John A Reynolds | |||
| Rachel Gorodkin | |||
| Sahena Haque | |||
| P2860 | cites work | Vitamin D concentrations in an UK inner-city multicultural outpatient population | Q22306150 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Vitamin D deficiency | Q27860616 | ||
| Vitamin D3 metabolism in patients with rheumatic diseases: Low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus | Q71809479 | ||
| Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
| 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543) | Q74102311 | ||
| Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture | Q74776728 | ||
| Systemic lupus erythematosus disease activity index 2000 | Q77624632 | ||
| Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases | Q81038411 | ||
| Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables | Q81411518 | ||
| Vitamin D deficiency in patients with active systemic lupus erythematosus | Q81577955 | ||
| Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study | Q82354836 | ||
| Vitamin D deficiency in a cohort of patients with systemic lupus erythematous from the South of Spain | Q84773468 | ||
| Active serum vitamin D levels are inversely correlated with coronary calcification | Q28250542 | ||
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. | Q33606850 | ||
| The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary | Q33729052 | ||
| Vitamin D and the immune system: new perspectives on an old theme | Q33888744 | ||
| Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
| Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases | Q34346370 | ||
| 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults | Q34485935 | ||
| Vitamin D deficiency and risk of cardiovascular disease | Q34586829 | ||
| Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study | Q34638516 | ||
| Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? | Q34660000 | ||
| Vitamin D deficiency in systemic lupus erythematosus | Q36375703 | ||
| Review: vitamin D, immunity and lupus | Q37035818 | ||
| Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose | Q37045709 | ||
| 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus | Q37448856 | ||
| Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis | Q37457135 | ||
| Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis | Q37719080 | ||
| Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. | Q40881448 | ||
| Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences | Q41941097 | ||
| Vitamin D insufficiency in a large female SLE cohort | Q43246258 | ||
| Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus | Q43282318 | ||
| Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. | Q43564632 | ||
| Vascular stiffness in women with systemic lupus erythematosus | Q43576508 | ||
| The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 | ||
| 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. | Q43775059 | ||
| 25-hydroxyvitamin D is not associated with carotid intima-media thickness in older men and women | Q43998822 | ||
| Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study | Q44652580 | ||
| Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus | Q45722050 | ||
| The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. | Q45929872 | ||
| Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. | Q45936681 | ||
| Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population | Q46086855 | ||
| Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality | Q46523052 | ||
| Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus | Q46724748 | ||
| Vitamin D status and markers of bone turnover in Caucasian and South Asian postmenopausal women living in the UK. | Q51407698 | ||
| Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. | Q51608826 | ||
| Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. | Q51973496 | ||
| Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. | Q52331664 | ||
| B-mode-detected carotid artery plaque in a general population. Atherosclerosis Risk in Communities (ARIC) Study Investigators. | Q52881804 | ||
| A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery. | Q52893018 | ||
| Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors | Q68556850 | ||
| P433 | issue | 3 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| aorta | Q101004 | ||
| P304 | page(s) | 544-551 | |
| P577 | publication date | 2011-11-24 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus | |
| P478 | volume | 51 |
| Q39132827 | 1,25(OH)2D3-mediated amelioration of aortic injury in streptozotocin-induced diabetic rats |
| Q35086343 | 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort |
| Q36108989 | A Pilot Study to Determine if Vitamin D Repletion Improves Endothelial Function in Lupus Patients |
| Q51315899 | Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus. |
| Q35525108 | Atherosclerosis in systemic lupus erythematosus |
| Q51013806 | Both high and low plasma levels of 25-hydroxy vitamin D increase blood pressure in a normal rat model. |
| Q51655680 | Brief Report: Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q38554636 | Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review |
| Q51125181 | Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus. |
| Q38222914 | Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum VitD confounders |
| Q36100744 | Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes |
| Q26777207 | Immune Response Modulation by Vitamin D: Role in Systemic Lupus Erythematosus |
| Q38883883 | Immunomodulators in SLE: Clinical evidence and immunologic actions |
| Q34213057 | Incidence of Vitamin D Insufficiency in Coastal South-Eastern US Patient Population With Cardiovascular Disease |
| Q46173910 | Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus. |
| Q92511792 | Links between High-Sensitivity C-Reactive Protein and Pulse Wave Analysis in Middle-Aged Patients with Hypertension and High Normal Blood Pressure |
| Q35592374 | Links between Vitamin D Deficiency and Cardiovascular Diseases |
| Q36187603 | Potential benefits of vitamin D for patients with systemic lupus erythematosus |
| Q43900414 | Premature coronary heart disease in SLE: can we prevent progression? |
| Q39730854 | Prevalence and predictors of vitamin D insufficiency in supplemented and non-supplemented women with systemic lupus erythematosus in the Mediterranean region |
| Q38026775 | The beneficial role of vitamin D in systemic lupus erythematosus (SLE). |
| Q34576314 | The clinical significance of vitamin D in systemic lupus erythematosus: a systematic review |
| Q90415132 | The effect of vitamin D on disease activity, fatigue and interferon signature gene expression in systemic lupus erythematosus |
| Q39147436 | Topics on vitamin D in systemic lupus erythematosus: analysis of evidence and critical literature review |
| Q38149851 | Transient ischemic attack and stroke in systemic lupus erythematosus |
| Q38844782 | Update on cardiovascular disease in lupus |
| Q37288736 | Vitamin D Deficiency in Egyptian Systemic Lupus Erythematosus Patients: How Prevalent and Does It Impact Disease Activity? |
| Q37583123 | Vitamin D and cardiovascular disease: is the evidence solid? |
| Q90330804 | Vitamin D and connective tissue diseases |
| Q46395898 | Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity |
| Q47855511 | Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians |
| Q38103285 | Vitamin D and systemic lupus erythematosus: an update |
| Q38293366 | Vitamin D and systemic lupus erythematosus: continued evolution |
| Q37234685 | Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus |
| Q36634362 | Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus |
| Q36983027 | Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio |
| Q36511431 | Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. |
| Q38834399 | Vitamin D treatment for connective tissue diseases: hope beyond the hype? |
| Q44125096 | What's new in internal medicine? |
Search more.